Medication info
Itex Olmesartan Tablets 20mg (Olmesartan Medoxomil)

Itex Olmesartan Tablets 20mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›20mg / 1 tablet
Manufacturer / importer
Teragen Itex Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100898 · Approved 2011.02.24 · Insurance code 698502100

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be started at a low dose while their condition is monitored closely. <Elderly patients> No dosage adjustment is necessary when this drug is administered to patients aged 65 years or older. Although no overall differences in the efficacy or safety of this drug have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.
Child dose
<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Ingredients

Manufacturer
Teragen Itex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a chronic disease characterized by persistently high blood pressure without a specific cause. This medication reliably lowers blood pressure, reducing strain on the heart and blood vessels. Regular use can also help prevent complications. Therefore, it is used for the treatment of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase the dose to 20mg once daily. If further blood pressure reduction is needed, the dose may be increased to a maximum of 40mg daily. The blood pressure-lowering effect appears within 2 weeks after starting treatment and reaches its maximum after approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered in combination with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended that the drug be taken at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, especially those with renal impairment), it is recommended that treatment be started at a low dose while their condition is monitored closely. <Elderly patients> No dosage adjustment is necessary when this drug is administered to patients aged 65 years or older. Although no overall differences in the efficacy or safety of this drug have been observed between elderly and younger patients, a more sensitive response in some elderly patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild or moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dosage adjustment is necessary for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, which may be increased to a maximum of 20mg daily. Use in patients with severe hepatic impairment is not recommended because there is no experience with its use in these patients.

Child dose

<Pediatric patients> The safety and efficacy in pediatric patients have not been established.

Precautions

This medication can cause severe harm, including injury or even death to the fetus or newborn if taken during the second or third trimester of pregnancy, so it should be stopped immediately upon confirmation of pregnancy. Individuals allergic to any components of this drug, those who are pregnant or breastfeeding, those undergoing kidney dialysis, those with severe liver impairment, those with biliary obstruction, and those with lactose intolerance should not take this medication. Individuals with reduced blood volume or low sodium levels may experience hypotension when starting this medication and should be monitored closely. If hypotension occurs, it is advised to lie down and rest and, if necessary, administer normal saline. Patients with severe heart failure or impairment of kidney function should use this medication with caution due to the risk of worsening kidney function, and blood potassium levels and kidney function should be regularly monitored. Due to the risk of hyperkalemia, especially in patients with heart or kidney disease, serum potassium levels should be frequently checked. Since this medication lowers blood pressure, dizziness may occur, so caution is required when driving or operating dangerous machinery. While taking this medication, be cautious, as combining it with potassium-sparing diuretics or potassium supplements can increase blood potassium levels, and taking it with other antihypertensive medications can enhance blood pressure-lowering effects. The combination of lithium with this drug is not recommended, as it can raise lithium levels and cause side effects. Taking non-steroidal anti-inflammatory drugs (NSAIDs) in conjunction with this medication can increase the risk of kidney function deterioration, necessitating regular kidney function tests. Taking this drug during pregnancy can lead to serious issues such as decreased fetal kidney function, oligohydramnios, and malformations, so it should not be taken during pregnancy. For breastfeeding, discontinuation of either the medication or breastfeeding is advised to avoid transmission to the baby. Safety and efficacy in pediatric patients have not been established, thus precaution is advised when administering to children. Overdose may lead to hypotension and palpitations, and severe symptoms warrant immediate medical attention. While taking this medication, regular liver function and blood tests should be performed to check for adverse reactions; if severe diarrhea or abdominal pain occurs, consult with a healthcare provider immediately.

Side effects

  • Dizziness
  • low back pain
  • bronchitis
  • increased creatine phosphokinase
  • diarrhea
  • headache
  • hematuria
  • hyperglycemia
  • hypertriglyceridemia
  • influenza-like symptoms
Show 39 more
  • pharyngitis
  • rhinitis
  • sinusitis
  • cough
  • chest pain
  • peripheral edema
  • vertigo
  • abdominal pain
  • indigestion
  • gastritis
  • nausea
  • palpitations
  • hypercholesterolemia
  • hyperlipidemia
  • hyperuricemia
  • arthralgia
  • arthritis
  • myalgia
  • rash
  • facial edema
  • weakness
  • vascular edema
  • anaphylactic reaction
  • vomiting
  • chronic malabsorption syndrome
  • intestinal vascular edema
  • rhabdomyolysis
  • hyperkalemia
  • acute renal failure
  • elevated serum creatinine
  • hair loss
  • pruritus
  • urticaria
  • autoimmune hepatitis
  • hypertension
  • epistaxis
  • asthma
  • postural dizziness
  • palpitations

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. The recommended storage temperature is between 1 to 25 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.